Prot #c12-097: NU MSK12U08: A Phase 1/2 study combining Ipilimumab with Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-Naïve Patients with Progressive Metastatic Castration-Resistant Prostate Cancer

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

Effective start/end date11/11/1411/11/17


  • Memorial Sloan-Kettering Cancer Center (Prot #c12-097: NU MSK12U08 // Prot #c12-097: NU MSK12U08)
  • Bristol-Myers Squibb Company (Prot #c12-097: NU MSK12U08 // Prot #c12-097: NU MSK12U08)